<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The author studied 189 patients with the main forms of phakomatosis (Louis-Barre <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">syndrome, Sturge-Weber</z:e>, <z:e sem="disease" ids="C0019562" disease_type="Disease or Syndrome" abbrv="">Hippel-Lindau disease</z:e> and <z:e sem="disease" ids="C1406030" disease_type="Neoplastic Process" abbrv="">Recklinghausens</z:e> <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo>.) The use of pathogenetical treatment in the Louis-Barre syndrome (a transplantation of a neonatal thymus with the bone marrow) promoted an improvement in the clinico-immunological indices </plain></SENT>
<SENT sid="1" pm="."><plain>A study of familial forms of the Louis-Barre syndrome and the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber disease</z:e> demonstrated a similarity according to the main clinical indices among the sibs in 80% which may speak of the role of the genetical factors in the formation of the disease </plain></SENT>
</text></document>